WORK Medical Technology Group Ltd, a company operating within the Health Care sector, is currently listed on the Nasdaq. As a holding company, WORK Medical Technology Group Ltd oversees subsidiaries that are engaged in the development, manufacturing, and supply of various medical devices. These include medical face masks, artery compression tourniquets for bleeding control, and disposable breathing circuits designed for the delivery of oxygen and anesthetic gases.
As of December 22, 2025, the company’s stock is in a trading halt, pending further information. The most recent closing price before the halt was $0.053. Over the past year, the stock has experienced significant volatility, with its highest valuation reaching $600.00 on February 19, 2025. Conversely, the lowest recorded value was $0.046 on December 16, 2025. The current close price, as of December 22, 2025, stands at $0.049.
The company’s market capitalization is valued at $54,700 USD. Financial metrics indicate a price-to-earnings (P/E) ratio of -0.13, suggesting that the company is trading at a loss relative to its earnings. Additionally, the price-to-book (P/B) ratio is 0.00400045, reflecting a valuation significantly below its book value. These metrics highlight the company’s current financial standing, which is trading well below both its earnings and book values.
No new corporate actions or disclosures have been reported since the last update on October 21, 2025. The trading halt remains in effect as the company awaits further developments or announcements. This situation underscores the importance of forthcoming information that could potentially impact the company’s market performance and investor perception.
